NFG
BMY icon

Next Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Next Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1.53M Sell
24,531
-2,919
-11% -$171K 0.1% 221
2021
Q3 		$1.63M Buy
27,450
+2,140
+8% +$141K 0.13% 180
2021
Q2 		$1.69M Sell
25,310
-992
-4% -$64.7K 0.14% 172
2021
Q1 		$1.66M Buy
26,302
+5,933
+29% +$369K 0.15% 152
2020
Q4 		$1.26M Sell
20,369
-8,086
-28% -$497K 0.12% 173
2020
Q3 		$1.72M Buy
28,455
+1,236
+5% +$74.4K 0.18% 122
2020
Q2 		$1.6M Sell
27,219
-7,135
-21% -$427K 0.19% 135
2020
Q1 		$1.92M Sell
34,354
-13,507
-28% -$826K 0.25% 92
2019
Q4 		$3.07M Sell
47,861
-1,117
-2% -$64K 0.32% 70
2019
Q3 		$2.48M Sell
48,978
-9,293
-16% -$437K 0.27% 83
2019
Q2 		$2.64M Buy
58,271
+44,675
+329% +$2.08M 0.28% 76
2019
Q1 		$649K Sell
13,596
-4,004
-23% -$199K 0.16% 81
2018
Q4 		$915K Buy
17,600
+3,104
+21% +$167K 0.19% 135
2018
Q3 		$900K Sell
14,496
-4,182
-22% -$248K 0.42% 46
2018
Q2 		$1.03M Sell
18,678
-1,917
-9% -$104K 0.4% 62
2018
Q1 		$1.3M Buy
20,595
+1,597
+8% +$103K 0.27% 101
2017
Q4 		$1.16M Sell
18,998
-2,497
-12% -$156K 0.5% 54
2017
Q3 		$1.4M Sell
21,495
-5,915
-22% -$345K 0.39% 62
2017
Q2 		$1.53M Buy
27,410
+774
+3% +$42.1K 0.37% 58
2017
Q1 		$1.49M Sell
26,636
-5,567
-17% -$305K 0.42% 55
2016
Q4 		$1.88M Buy
32,203
+78
+0.2% +$4.26K 0.33% 61
2016
Q3 		$1.73M Buy
32,125
+9,637
+43% +$619K 0.31% 66
2016
Q2 		$1.65M Sell
22,488
-225
-1% -$15.9K 0.52% 37
2016
Q1 		$1.45M Sell
22,713
-157
-0.7% -$9.9K 0.51% 43
2015
Q4 		$1.57M Buy
22,870
+563
+3% +$37.2K 0.59% 30
2015
Q3 		$1.32M Buy
22,307
+3,254
+17% +$206K 0.47% 46
2015
Q2 		$1.27M Buy
19,053
+429
+2% +$28.3K 0.44% 55
2015
Q1 		$1.2M Sell
18,624
-1,202
-6% -$75.2K 0.39% 69
2014
Q4 		$1.17M Sell
19,826
-15,348
-44% -$866K 0.39% 59
2014
Q3 		$1.8M Sell
35,174
-453
-1% -$22.6K 0.36% 50
2014
Q2 		$1.75M Buy
+35,627
New +$1.76M 0.91% 17

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Next Financial Group's BMY Position: Q4 2021 in Review

Next Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q4 2021, selling an estimated $171K and leaving 24,531 shares worth $1.53M. The position accounts for 0.1% of the portfolio, ranked #221.

Next Financial Group first reported a position in BMY in Q2 2014 and has held it in 31 quarters since. The position peaked at $3.07M in Q4 2019. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Next Financial Group held 24,531 shares of Bristol-Myers Squibb worth $1.53M as of Q4 2021.
  • Next Financial Group sold 2,919 Bristol-Myers Squibb shares in Q4 2021, an estimated $171K.
  • Bristol-Myers Squibb made up 0.1% of Next Financial Group's portfolio in Q4 2021, its #221 holding.
  • Next Financial Group first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 31 quarters since.
  • Next Financial Group's Bristol-Myers Squibb position peaked at $3.07M in Q4 2019.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.